Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06336928 · ClinicalTrials.gov registry record
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
A clinical trial of Breast Carcinoma, sponsored by University of Southern California.
- Recruiting
- Registry status
- 490
- Enrollment target
- 4
- Study locations
NCT06336928 is a study of Breast Carcinoma that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 490 participants, below the 766-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (36% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT06336928, a study of Breast Carcinoma, is actively recruiting participants, sponsored by University of Southern California.
- RECRUITING
- Registry status
- 490 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (4)
California
- Keck Medicine of USC Koreatown - Los Angeles
- Los Angeles General Medical Center - Los Angeles
- USC / Norris Comprehensive Cancer Center - Los Angeles
- USC Norris Oncology/Hematology-Newport Beach - Newport Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 490 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2030-06-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06336928
The ClinicalTrials.gov registry entry for NCT06336928 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 490 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 766-participant average among 106 other Breast Carcinoma trials with a reported enrollment target (36% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Breast Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06336928 reports 4 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06336928 about?
NCT06336928 is a clinical study titled "A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis". This study evaluates whether a special type of blood analysis, called liquid biopsy (LBx), correlates with mammography results and/or diagnosis of breast cancer.
What is the current status of trial NCT06336928?
This trial is currently recruiting. The enrollment target is 490 participants. The study started on 2024-06-07. Estimated completion is 2030-06-07.
What conditions does trial NCT06336928 study?
This clinical trial studies the following conditions: Breast Carcinoma.
What interventions are being tested in trial NCT06336928?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06336928?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06336928 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surviving Daily Life
RECRUITING
-
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Congestive Heart Failure Receiving Therapy for Breast Cancer
RECRUITING
-
Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
RECRUITING · Phase 2
-
Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
RECRUITING · Phase 2
-
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
RECRUITING
-
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.